News from oncosec medical incorporated A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:ONCS)

Feb 03, 2016, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Present at Prominent Investment Conferences in February

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today...

Jan 06, 2016, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Present at Prominent Investment Conferences in January

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that...

Dec 17, 2015, 13:01 ET
OncoSec opens new headquarters and research facility in San Diego. Credit: Jonathan Mantell

OncoSec Opens New Headquarters and Research Facility in San Diego

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

Dec 08, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Announces First Quarter Results for Fiscal Year End 2016

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

Dec 02, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information

OncoSec to Present at ICV Manhattan

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that...

Nov 19, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2015

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

Nov 09, 2015, 16:05 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Closes $7.5 Million Registered Direct Offering

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that...

Nov 03, 2015, 20:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Announces $7.5 Million Registered Direct Offering

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today...

Oct 29, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Enrolls First Patient in Biomarker-Focused Pilot Study in Triple Negative Breast Cancer

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that...

Oct 27, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Issues Annual Letter To Shareholders

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today issued the below...

Oct 14, 2015, 17:31 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Announces Fourth Quarter and YTD Results for Fiscal Year End 2015

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

Oct 05, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Present at Investment Conferences in October

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today...

Oct 01, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Host Fourth Quarter Financial Results Conference Call and Live Webcast on October 15, 2015

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that...

Sep 27, 2015, 12:15 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Announces Positive Results from Phase II Trial of ImmunoPulse™ IL-12 in Merkel Cell Carcinoma

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

Sep 14, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Appoints David P. Meininger, PhD, MBA, as Senior Vice President of Business Development

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

Sep 09, 2015, 10:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Presents Advancements in Intratumoral Gene Electro-Transfer Devices for Immuno-Oncology

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented recent...

Sep 02, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Present at Scientific and Investment Conferences in September

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today...

Aug 24, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Promotes Sheela Mohan-Peterson to Chief Legal and Compliance Officer

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, promoted Sheela...

Aug 18, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Announces First Patient Enrolled in Phase II Clinical Trial Evaluating Combination of ImmunoPulse™ IL-12 and Anti-PD-1 Treatment

 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced...

May 27, 2015, 13:09 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Announces Uplisting to The NASDAQ Stock Market LLC

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the...